Abstract
We report a case of immune-mediated myelopathy occurring 4 months after unrelated bone marrow transplantation for myelodysplastic syndrome. After the tapering of cyclosporine for graft-versus-host disease prophylaxis, the patient developed several neurological symptoms mimicking the clinical features of multiple sclerosis (MS).Although neurological exacerbation was well stabilized with a bulk dose of corticosteroid, sustained improvement of neurological deficits occurred after the patient developed hematopoietic mixed chimerism (HMC).This experience may provide clinical evidence supporting the current therapeutic concept, in which HMC induction can potentially cure several immune diseases, including MS.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Saiz A, Graus F. Neurological complications of hematopoietic cell transplantation. Semin Neurol. 2004;24:427–434.
Sostak P, Padovan CS, Yousry TA, et al. Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology. 2003;60:842–848.
Padovan CS, Yousry TA, Schleuning M, et al. Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation. Ann Neurol. 1998;43:627–633.
Matsumoto H, Seki N, Yamamoto T, et al. A case of asymmetric demyelinating neuropathy in a patient with chronic graft-versus-host disease. Rinsho Shinkeigaku. 2005;45:748–753.
Sakai M, Ohashi K, Kobayashi T, et al. Meningeal hematopoiesis following radiation myelitis in a hematopoietic stem-cell transplant recipient. Am J Hematol. 2005;79:291–293.
Rouah E, Gruber R, Shearer W, et al. Graft-versus-host disease in the central nervous system. A real entity? Am J Clin Pathol. 1998; 89:543.
Kida A, Ohashi K, Kobayashi T, et al. Incapacitating lower limb pain syndrome in cord blood stem cell transplant recipients with calcineurin inhibitor. Pathol Oncol Res. 2004;10:204–206.
Kida A, Ohashi K, Tanaka C, et al. Calcineurin-inhibitor pain syndrome following haematopoietic stem cell transplantation. Br J Haematol. 2004;126:288.
Solaro C, Murialdo A, Giunti D, et al. Central and peripheral nervous system complications following allogeneic bone marrow transplantation. Eur J Neurol. 2001;8:77–80.
Saito N, Tanaka T, Matsuda S et al. A case of inflammatory demyelinative myelopathy after bone marrow transplantation. Rinsho Shinkeigaku. 2000;40:556–560.
Openshaw H, Slatkin NE, Parker PM, Forman SJ. Immune-mediated myelopathy after allogeneic marrow transplantation. Bone Marrow Transplant. 1995;15:633–6.
Hickey WF, Kimura H. Graft-vs.-host disease elicits expression of class I and class II histocompatibility antigens and the presence of scattered T lymphocytes in rat central nervous system. Proc Natl Acad Sci U S A. 1987;84:2082–2086.
Baron F, Baker JE, Storb R, et al. Kinetics of engraftment in patients with hematologic malignancies given allogeneic hemato-poietic cell transplantation after nonmyeloablative conditioning. Blood. 2004;104:2254–2262.
Barta A, Batai A, Kelemen E, et al. Immunological importance of chimerism in transplantation: new conditioning protocol in BMT and the development of chimeric state. Hum Immunol. 2000;61: 101–110.
Sykes M, Nikolic B. Treatment of severe autoimmune disease by stem-cell transplantation. Nature. 2005;435:620–627.
Author information
Authors and Affiliations
About this article
Cite this article
Sakai, M., Ohashi, K., Yamashita, T. et al. Immune-Mediated Myelopathy following Allogeneic Stem Cell Transplantation. Int J Hematol 84, 272–275 (2006). https://doi.org/10.1532/IJH97.06060
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1532/IJH97.06060